cathepsin
b
potenti
target
develop
drug
treat
sever
import
human
diseas
number
inhibitor
target
protein
develop
past
sever
year
recent
group
small
molecul
identifi
inhibitori
activ
cathepsin
b
high
throughput
screen
ht
test
studi
tradit
continu
binari
qsar
model
built
classifi
biolog
activ
previous
identifi
compound
distinguish
activ
compound
inact
compound
drug
develop
base
calcul
molecular
physicochem
properti
strong
correl
obtain
continu
qsar
model
regress
correl
coeffici
r
crossvalid
correl
coeffici
q
compound
compound
set
exclud
outlier
respect
model
valid
leaveoneout
loo
method
trainingtest
set
method
binari
model
demonstr
strong
level
predict
distinguish
activ
compound
inact
compound
accuraci
activ
inact
compound
respect
noncrossvalid
model
similar
result
obtain
crossvalid
model
collect
result
demonstr
model
abil
discrimin
activ
inact
compound
suggest
model
may
use
prescreen
compound
facilit
compound
optim
design
novel
inhibitor
drug
develop
publish
elsevi
inc
member
papain
superfamili
cathepsin
involv
mani
biolog
process
relat
human
diseas
disord
previous
identifi
cathepsin
includ
cathepsin
b
h
k
l
sever
protein
select
biolog
target
develop
therapeut
treatment
number
inhibitor
identifi
develop
mani
enzym
cathepsin
b
inhibitor
highli
sought
chemic
agent
sinc
mani
diseas
neurodegen
disord
cardiovascular
diseas
cancer
inflamm
rheumatoid
arthriti
alzheim
diseas
connect
unusu
level
abnorm
function
cathepsin
b
ubiquit
lysosom
cystein
proteas
cathepsin
b
found
respons
intracellular
well
extracellular
proteolysi
mammalian
cell
facilit
cell
migrat
dissolv
extracellular
barrier
result
tumor
metastasi
angiogenesi
biolog
activ
function
cathepsin
b
also
import
viral
infect
replic
sever
virus
ebola
sar
sever
acut
respiratori
syndrom
human
cell
due
import
biolog
function
directli
relat
sever
import
human
diseas
cathepsin
b
chosen
drug
develop
target
mani
effort
number
compound
found
inhibit
cathepsin
b
activ
compound
test
effect
anim
experi
cathepsin
inhibitor
disabl
biolog
activ
cathepsin
b
form
irrevers
coval
chemic
bond
catalyt
site
enzym
irrevers
inhibitor
includ
dipeptidyl
nitril
vinyl
sulfon
expoxysuccin
acyloxymethyl
keton
fluoromethyl
keton
hydrazid
bisaamidoketon
structur
studi
provid
detail
insight
biolog
mechan
inhibitor
inhibitor
bind
catalyt
activ
site
cathepsin
b
form
irrevers
coval
bond
protein
activ
site
meanwhil
comput
studi
dock
virtual
screen
also
use
explor
bind
tabl
compound
structur
biolog
activ
activ
inact
compound
pubchem
bioassay
databas
inhibit
mechan
inhibitor
comput
approach
prove
effici
essenti
optim
design
chemic
agent
improv
biolog
activ
effort
identifi
chemic
probe
high
throughput
screen
ht
technolog
number
chemic
found
activ
cathepsin
b
screen
campaign
inhibitor
identif
nih
molecular
librari
program
mlp
screen
result
deposit
pubchem
http
pubchemncbinlmnihgov
databas
molecular
structur
associ
biolog
activ
avail
gener
public
databas
contain
structur
biolog
activ
ic
deriv
doserespons
ht
experi
activ
compound
test
previou
studi
dock
simul
use
model
bind
structur
activ
compound
identifi
high
throughput
screen
ht
test
bind
site
protein
rel
bind
affin
calcul
compound
studi
base
respect
model
bound
structur
use
linear
respons
molecular
mechan
poisson
boltzmannsurfac
area
method
lrmmpbsa
strong
correl
calcul
bind
affin
experiment
biolog
activ
obtain
threedimension
compar
molecular
field
analysi
comfa
quantit
structureact
relationship
qsar
model
also
establish
base
multiconform
method
high
correl
coeffici
activ
compound
publish
given
import
enzym
diseas
treatment
broad
research
interest
screen
identifi
potent
inhibitor
effort
taken
build
qsar
model
correl
molecular
physicochem
properti
biolog
activ
compound
test
cathepsin
b
inhibit
screen
experi
effort
also
undertaken
build
statist
model
classifi
inhibit
activ
cathepsin
b
specif
compound
work
report
result
continu
continu
bioactiv
space
binari
two
discret
bioactiv
statu
eg
activ
vs
inact
qsar
model
order
obtain
insight
relationship
chemic
structur
physicochem
propertiesbiolog
activ
addit
result
work
may
provid
mean
prescreen
compound
facilit
silico
design
de
novo
cathepsin
b
inhibitor
develop
drug
treatment
variou
human
diseas
use
molecular
target
chemic
structur
small
molecul
compound
first
convert
molecular
structur
obtain
pubchem
databas
pubchem
bioassay
access
subsequ
subject
energi
minim
calcul
root
mean
squar
deviat
rmsd
potenti
energi
smaller
use
optim
potenti
liquid
simul
opl
forc
field
molecular
oper
environ
moe
program
version
develop
chemic
comput
group
montreal
canada
bioassay
aid
pubchem
bioassay
access
compound
test
doserespons
confirmatori
screen
experi
wherea
compound
confirm
inhibitori
activ
compound
confirm
inhibitori
activ
bioactiv
outcom
remain
compound
report
inconclus
examin
activ
compound
use
differ
experiment
protocol
assay
depositor
suggest
like
artifact
investig
use
sever
independ
bioassay
test
differ
biolog
experi
may
affect
similar
caus
artifact
suggest
five
compound
bear
greater
chanc
fals
posit
remov
current
analysi
activ
inact
compound
bioassay
includ
work
bioassay
employ
similar
experiment
protocol
bioassay
compound
test
compound
confirm
inhibitori
activ
compound
confirm
inhibitori
activ
one
compound
report
inconclus
four
activ
compound
uniqu
structur
ad
activ
compound
list
total
activ
compound
bioassay
bioassay
inact
compound
bioassay
bioassay
use
model
averag
ic
report
bioassay
deposit
use
bioactiv
activ
compound
pubchem
compound
access
cid
molecular
formula
biolog
activ
ic
compound
list
tabl
one
activ
compound
includ
qsar
model
conform
obtain
dock
simul
molecular
structur
inform
obtain
pubchem
websit
base
cid
http
pubchemncbinlmnihgov
bioassay
protocol
inform
obtain
pubchem
websit
bioassay
id
aid
http
pubchemncbinlmnihgovassayassaycgi
http
pubchemncbinlmnihgovassayassaycgi
compound
test
confirmatori
assay
cherri
pick
base
screen
result
compound
singl
dose
ht
assay
potenti
cathepsin
b
inhibit
activ
pubchem
aid
measur
releas
fluorophor
aminomethyl
coumarin
amc
hydrolysi
amclabel
dipeptid
larg
number
inact
compound
primari
ht
assay
includ
model
sinc
statist
method
typic
perform
well
unbalanc
data
set
therefor
claim
compound
inact
yield
accuraci
point
wei
et
al
threedimension
structur
coordin
cathepsin
protein
bound
dipeptidyl
nitril
dpn
obtain
protein
databank
pdb
code
pdb
file
crystallograph
structur
complex
cathepsin
b
contain
three
chain
b
c
first
two
chain
form
dimer
use
dock
simul
fig
hydrogen
atom
partial
charg
ad
protein
short
step
minim
perform
relax
newli
ad
hydrogen
atom
potenti
steric
contact
origin
pdb
coordin
minim
perform
use
opl
forc
field
follow
standard
protocol
glide
program
version
firstdiscoveri
suit
minim
protein
structur
use
gener
dock
grid
use
dock
activ
compound
dpn
bind
site
dock
box
exterior
box
placement
ligand
atom
restrain
box
interior
box
placement
ligand
geometr
center
use
gener
dock
grid
box
center
geometr
center
dpn
ligand
default
valu
use
set
within
glide
version
activ
compound
flexibl
dock
activ
site
cathepsin
protein
base
gener
dock
grid
dock
simul
carri
use
glide
program
detail
dock
simul
obtain
previous
report
work
dock
simul
use
determin
activ
conform
compound
accord
structur
physicochem
properti
bind
site
conform
inact
compound
model
flexibl
align
conform
dpn
ligand
crystal
complex
align
carri
base
molecular
shape
volum
pharmacophor
element
use
flexibl
align
modul
implement
moe
default
paramet
use
flexibl
align
conform
activ
compound
also
obtain
use
align
comparison
conform
obtain
dock
simul
qsar
model
partial
leastsquar
pl
analysi
method
use
conduct
statist
analysi
deriv
continu
qsar
model
base
descriptor
calcul
inhibitor
pl
method
prove
prioriti
method
statist
analysi
especi
case
number
descriptor
larg
pl
calcul
carri
modul
implement
moe
log
ic
valu
use
depend
variabl
calcul
molecular
physicochem
properti
use
independ
variabl
analysi
descriptor
calcul
preliminari
factor
analysi
conduct
obtain
optimum
correl
individu
descriptor
biolog
activ
log
ic
nine
descriptor
list
tabl
select
use
build
qsar
model
optim
number
compon
compon
continu
model
binari
model
use
build
final
model
model
valid
carri
leaveoneout
loo
crossvalid
procedur
trainingtest
set
approach
compound
split
train
set
model
build
test
set
activ
predict
built
model
continu
binari
model
valid
loo
three
trainingtest
experi
nine
compound
randomli
select
test
compound
compound
use
train
set
qsar
model
build
loo
techniqu
provid
good
way
quantit
evalu
predict
abil
robust
model
predict
compound
activ
use
qsar
model
built
base
inform
remain
compound
avoid
effect
compound
activ
predict
approach
tri
elimin
overfit
problem
normal
exist
convent
regress
method
includ
compound
model
construct
crossvalid
correl
coeffici
q
use
measur
predict
model
convent
correl
coeffici
r
use
measur
qualiti
model
order
calcul
physicochem
molecular
propertybas
descriptor
build
qsar
model
confirm
studi
compound
need
structur
compound
first
convert
structur
state
section
total
activ
compound
inact
compound
uniqu
structur
obtain
two
confirmatori
bioassay
data
entri
pubchem
aid
dock
simul
molecular
align
method
appli
obtain
activ
confirm
activ
compound
dock
simul
activ
compound
dock
activ
site
cathepsin
b
use
methodolog
confirm
determin
procedur
describ
previous
reliabl
dock
pose
obtain
one
compound
detail
result
discuss
conform
select
comparison
compound
found
previou
report
result
compound
dock
result
includ
qsar
model
dock
cluster
activ
compound
depict
fig
seen
compound
dock
bind
site
compar
bind
conform
roughli
similar
locat
molecular
align
activ
inact
compound
superpos
onto
dpn
use
flexibl
molecular
align
method
best
fit
conform
compound
select
fit
score
base
molecular
shape
occupi
volum
pharmacophor
match
includ
hydrogen
donor
hydrogen
acceptor
hydrophob
atom
polar
hydrogen
atom
aromat
two
molecul
conform
compound
select
base
best
fit
moe
two
separ
set
molecular
structur
prepar
one
base
dock
structur
activ
compound
molecular
align
inact
compound
base
molecular
align
compound
two
set
structur
use
build
qsar
model
comparison
yield
similar
result
inform
includ
pubchem
compound
access
eg
cid
molecular
formula
smile
simplifi
molecular
input
line
entri
specif
string
molecular
weight
mw
activ
ic
obtain
pubchem
bioassay
databas
aid
compound
use
work
list
tabl
build
binari
qsar
model
activ
activ
inact
compound
assign
respect
descriptor
avail
moe
qsar
modul
initi
select
descriptor
attempt
empir
base
natur
descriptor
featur
studi
molecular
set
problem
studi
relev
model
total
energi
heat
format
number
bromin
boron
fluorin
phosphoru
atom
elimin
consider
work
descriptor
physicochem
molecular
properti
select
calcul
studi
compound
base
construct
conform
use
method
implement
moe
version
factor
analys
perform
examin
correl
individu
descriptor
biolog
activ
log
ic
compound
nine
descriptor
demonstr
appar
correl
observ
biolog
activ
chosen
build
qsar
model
list
tabl
among
descriptor
n
accdon
sum
count
hydrogen
acceptor
donor
apol
mr
dipol
sum
atom
polariz
molar
refract
dipol
moment
molecul
calcul
partial
charg
molecul
respect
sa
sa
pol
water
access
surfac
area
wasa
whole
molecul
hydrophil
part
wasa
calcul
use
radiu
probe
respect
vol
e
sol
log
p
ow
molecular
volum
empir
solvat
energi
calcul
base
opl
forc
field
log
valu
octanolwat
partit
coeffici
compound
respect
descriptor
relat
molecular
solvat
properti
degre
calcul
molecular
solvat
partit
compound
hydrophob
hydrophil
compart
still
remain
challeng
combin
variou
comput
method
would
better
choic
estim
chemic
partit
properti
well
regard
direct
larg
effect
biolog
activ
convent
qsar
model
construct
activ
compound
base
measur
biolog
activ
log
ic
use
pl
regress
method
model
entir
compound
set
first
built
examin
model
coher
compound
identifi
potenti
outlier
model
valid
use
loo
method
three
trainingtest
set
examin
predict
robust
qsar
model
extend
predict
spectrum
includ
inact
compound
seven
inact
compound
randomli
chosen
includ
model
inhibitori
activ
read
compound
max
test
concentr
mm
close
read
control
experi
assum
ic
exist
much
higher
mm
enabl
numer
analysi
valu
assign
ic
five
inact
compound
qsar
analysi
predict
result
predict
error
model
base
compound
model
list
tabl
two
threshold
one
half
unit
respect
use
valid
calcul
result
former
correspond
variat
rang
rang
singl
order
magnitud
direct
experiment
valu
ic
latter
correspond
variat
rang
within
window
singl
order
magnitud
ic
nonvalid
model
base
descriptor
properti
show
strong
abil
predict
biolog
activ
error
differ
predict
valu
experiment
valu
smaller
one
unit
compound
twentysix
compound
predict
error
smaller
equal
unit
model
model
evalu
use
loo
valid
method
gener
satisfactori
result
observ
activ
vs
predict
activ
nonvalid
fit
model
crossvalid
model
plot
fig
check
predict
result
crossvalid
model
note
three
compound
compound
predict
error
close
one
unit
three
compound
treat
outlier
exclud
model
construct
tabl
compound
predict
error
smaller
one
unit
nonvalid
model
compound
predict
error
smaller
unit
crossvalid
model
twentyseven
half
compound
predict
error
smaller
half
unit
accord
nonvalid
crossvalid
result
respect
crossvalid
result
demonstr
strong
predict
construct
model
applic
cathepsin
b
inhibit
activ
predict
evalu
model
predict
robust
three
addit
model
built
use
trainingtestset
method
compound
randomli
split
train
set
test
set
work
six
compound
randomli
select
test
set
process
repeat
three
time
predict
result
three
model
list
tabl
plot
observ
activ
vs
predict
activ
train
compound
test
compound
shown
fig
seen
predict
result
test
compound
close
experiment
activ
reason
deviat
three
model
base
train
set
compound
demonstr
similar
predict
result
summari
nonvalid
regress
coeffici
crossvalid
coeffici
root
mean
squar
error
rmse
model
respect
tabl
nonvalid
crossvalid
coeffici
rmse
outlier
model
respect
tabl
statist
result
three
trainingtest
model
also
list
tabl
three
model
base
train
set
compound
similar
statist
properti
model
describ
nonvalid
correl
coeffici
crossvalid
coeffici
predict
error
test
compound
one
compound
three
train
set
smaller
one
unit
model
tabl
two
test
compound
predict
error
larger
half
unit
model
compound
predict
error
larger
half
unit
result
show
predict
model
accept
consid
fact
compound
structur
bioactiv
studi
reason
divers
reason
conclud
model
demonstr
rel
strong
predict
power
estim
activ
unknown
compound
base
known
compound
avail
confirm
activ
inact
compound
provid
opportun
develop
binari
model
classifi
activ
cathepsin
b
inhibitor
inact
compound
although
modern
ht
technolog
allow
rapid
screen
ten
thousand
compound
matter
day
experi
expens
hardli
cover
chemic
space
silico
screen
help
elimin
potenti
inact
compound
build
compound
librari
enrich
promis
lead
candid
thu
silico
screen
cost
effici
strategi
facilit
identif
potenti
drug
candid
prescreen
provid
way
elimin
potenti
inact
molecul
novel
compound
design
synthesi
make
limit
experiment
resourc
avail
screen
potenti
activ
molecul
nine
descriptor
use
continu
model
also
use
build
binari
qsar
model
reli
method
develop
chemic
comput
group
implement
modul
moe
binari
qsar
model
develop
econom
qsar
model
use
distinguish
activ
vs
inact
compound
ht
experi
assist
model
drug
develop
binari
model
built
use
binari
method
modul
moe
similarli
process
continu
model
construct
binari
model
first
built
compound
examin
predict
model
insid
compound
compound
use
build
model
follow
valid
use
loo
method
three
trainingtest
set
examin
predict
robust
qsar
model
outsid
compound
predict
result
binari
model
list
tabl
statist
result
list
tabl
compound
except
four
activ
three
inact
one
predict
correctli
nonvalid
model
tabl
predict
accuraci
tabl
compound
activ
inact
compound
respect
demonstr
strong
classif
power
model
discrimin
inact
compound
activ
compound
addit
four
crossvalid
model
built
one
loo
three
trainingtestset
method
latter
three
model
compound
randomli
split
train
set
compound
test
set
compound
four
model
design
tabl
trainingtest
model
predict
activ
residu
compound
train
set
compound
test
set
tabl
trainingtest
model
predict
activ
residu
compound
train
set
compound
test
set
tabl
valid
model
clearli
demonstr
abil
distinguish
activ
vs
inact
compound
high
effici
accuraci
indic
strong
potenti
silico
screen
small
molecul
note
predict
accuraci
activ
compound
slightli
consist
lower
inact
compound
phenomenon
could
aris
unbalanc
natur
data
set
regard
bioactiv
class
activ
inact
work
larger
popul
inact
compound
activ
one
shift
split
point
use
determin
activ
vs
inact
activ
side
shift
result
activ
compound
border
line
solv
problem
one
could
design
weight
schema
overestim
type
compound
underrepres
data
set
mani
case
howev
unbal
would
caus
sever
effect
applic
method
focu
select
molecul
given
properti
elimin
inact
molecul
develop
activ
compound
design
cathepsin
b
inhibitor
avail
molecular
structur
inhibit
activ
cathepsin
b
identifi
ht
experi
provid
opportun
conduct
structureact
relationship
studi
facilit
chemic
probe
develop
potenti
drug
develop
relat
diseas
treatment
activ
conform
activ
compound
model
use
dock
simul
conform
inact
compound
determin
base
flexibl
align
compound
conform
origin
ligand
dpn
crystal
structur
complex
convent
continu
model
built
predict
cathepsin
b
inhibit
activ
activ
small
molecul
binari
model
construct
activ
vs
inact
classif
nine
molecular
physicochem
properti
calcul
base
conform
inform
select
use
descriptor
build
qsar
model
continu
model
demonstr
reason
correl
predict
observ
activ
nonvalid
r
crossvalid
q
regress
correl
coeffici
compound
compound
exclud
outlier
respect
model
show
strong
predict
reason
predict
error
rate
entir
test
set
across
sever
model
almost
compound
use
model
predict
error
smaller
one
unit
major
compound
predict
error
less
half
unit
nonvalid
crossvalid
result
predict
model
valid
use
three
trainingtest
method
result
predict
error
test
compound
smaller
one
unit
signific
fraction
less
half
unit
three
model
togeth
consist
perform
four
crossvalid
model
demonstr
model
robust
predict
inhibit
activ
small
molecul
biolog
system
cathepsin
b
success
qsar
model
prove
model
approach
base
dock
conform
determin
nine
physicochem
properti
may
promis
method
predict
biolog
activ
small
molecul
drug
develop
base
knowledg
deriv
identifi
cathepsin
b
inhibitor
furthermor
binari
model
built
classifi
cathepsin
b
inhibit
activ
eg
activ
vs
inact
categori
statist
result
show
model
demonstr
excel
perform
predict
accuraci
bioactiv
class
test
activ
inact
compound
nonvalid
binari
model
respect
compound
except
four
activ
three
inact
compound
correctli
predict
nonvalid
fit
model
similar
predict
result
obtain
crossvalid
model
three
trainingtest
model
bioactiv
categori
five
six
test
compound
predict
correctli
predict
accuraci
factor
model
yield
high
accuraci
upon
predict
cathepsin
b
inhibit
activ
demonstr
model
enabl
classif
activ
vs
inact
inhibitori
compound
high
accuraci
robust
feasibl
binari
method
indic
potenti
sever
applic
facilit
molecular
design
drug
develop
particular
approach
may
prove
highli
effici
prescreen
silico
design
compound
optim
biolog
activ
base
inform
known
bioactiv
compound
silico
prescreen
may
perform
filter
one
unlik
desir
biolog
activ
thu
allow
limit
effort
focus
highli
promis
candid
advantag
anticip
util
combin
continu
binari
classif
model
potenti
benefit
modern
drug
develop
therapeut
purpos
